Trishula Therapeutics Inc.

Trishula Therapeutics Inc. is engaged in clinical research focused on metastatic pancreatic adenocarcinoma, with attention to treatment strategies for patients who have not previously received systemic therapy.

• Metastatic pancreatic cancer
• First-line oncology treatment
• Solid tumor therapeutics

The sponsor’s research activity centers on therapeutic options for advanced pancreatic malignancy, reflecting interest in difficult-to-treat gastrointestinal cancers and associated clinical outcomes.